Subcortical ischemic vascular dementia: Assessment with quantitative MR imaging and 1H MR spectroscopy

American Journal of Neuroradiology

Volumn 21, Issue 4, 2000, Pages 621-630

  Capizzano, Aristides A ^a,b   Schuff, Norbert ^a,b   Amend, Diane L ^a,b   Tanabe, Jody L ^a,b   Norman, David ^b   Maudsley, Andrew A ^a   Jagust, William ^d   Chui, Helena C ^e   Fein, George ^c   Segal, Mark R ^c   Weiner, Michael W ^a,b,c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

AGED; ASPARTIC ACID; BRAIN ISCHEMIA; CREATINE; DEMENTIA, VASCULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 0034033404     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Roman GC. The epidemiology of vascular dementia. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin: Springer-Verlag, 1991:9-15
2. Yamaguchi T, Ogata J, Yoshida F. Epidemiology of vascular dementia in Japan: Proceedings of the NINDS-AIREN International Workshop on Vascular Dementia. National Institutes of Health, Bethesda, MD, April 19-21, 1991.
3. Suzuki K, Kutsuzawa T, Nakajinia K, Hatano S. Epidemiology of vascular dementia and stroke in Japan. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin: Springer-Verlag, 1991:16-24
4. Tomlinson BE, Henderson G. Some quantitative cerebral findings in normal and demented old people. In: Terry RD, Gershon S, eds. Neurobiology of Aging. New York: Raven Press, 1976
5. Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF. Classification, diagnosis and treatment of vascular dementia. Drugs Aging 1997;11:361-373
6. Roman GC, Tatemichi TK, Erkinjutti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260
7. Miller Fischer C. Lacunes: small, deep cerebral infarcts. Neurology 1965;15:774-784
8. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain 1988;111:1425-1439
9. Roman GC. From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke 1996;27:1269-1273
10. Caplan LR. Binswanger's disease-revisited. Neurology 1995;45: 626-633
11. De Reuck JL. Evidence for chronic ischemia in the pathogenesis of vascular dementia: from neuroPATH to neuroPET. Acta Neurol Belg 1996;96:228-231
12. Risberg J, Gustafson L. Regional cerebral blood flow measurements in the clinical evaluation of demented patients. Dement Geriatr Cogn Disord 1997:8:92-97
13. Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss WD. Vascular dementia: perfusional and metabolic disturbances and effects of therapy. J Neural Transin 1996[suppl];47:183-191
14. Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia: clinical and positron emission tomography findings. Arch Neurol 1995;52:773-780
15. De Reuck J, Decoo D, Marchau M, Santens P. Lemahieu I, Strijcknians K. Positron emission tomography in vascular dementia. J Neurol Sci 1998;154:55-61
16. Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27:408-414
17. Mochizuki Y, Oishi M, Takasu T. Cerebral blood flow in single and multiple lacunar infarctions. Stroke 1997;28:1458-1460
18. Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D. Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992;49:909-913
19. Hachinski VC, Potter P, Merskey H. Leuko-Araiosis. Arch Neurol 1987;44:21-23
20. Grafton ST, Sumi SM, Stimac GK, Alvord EC, Shaw C-M, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991;48:293-298
21. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981;5:549-564
22. 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31
23. Meyerhoff DJ, MacKay S, Constans J-M, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47
24. Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517-523
25. 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167-174
26. MacKay S, Ezekiel F, Di Sclafani V, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996;198:537-545
27. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513-1521
28. Schuff N, Amend D, Meyerhoff D. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 1998;207:91-102
29. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437
30. Tedescni G, Bertolino A, Lundbom N, et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 1996;47:696-704
31. Kattapong VJ, Brooks WM, Wesley MH, Kodituwakku PW, Rosenberg GA. Proton magnetic resonance spectroscopy of vascular-and Alzheimer-type dementia. Arch Neurol 1996;53:678-680
32. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997;28:1940-1943
33. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease diagnostic and treatment centers. Neurology 1992;42:473-480
34. Johst KA, Barnetson LPD, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Int Psychogeriatr 1997;9[suppl 1]:: 191-222
35. McKann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
36. Haupt CI, Schuff N, Weiner MW, Maudsley AA. Lipid removal in 1H spectroscopic imaging by data extrapolation. Magn Reson Med 1996;35:678-687
37. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-651
38. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-344
39. Tanabe J, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer's disease. Am J Neurmadiol 1997;18:115-123
40. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imaging 1992;10:471-485
41. Lu D, Margouleff C, Rubin E. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 1997;37:18-23
42. Pappata S, Mazoyer B, Tran Dinh S, Cambon H, Levasseur M, Baron JC. Effects of capsular or thalamic stroke on metabolism in the cortex and cerebellum: a positron tomography study. Stroke 1990;21:519-524
43. Fulham MJ, Dietz MJ, Duyn JH, Shih HH-L, Alger JR, Di Chiro G. Transsynaptic reduction in N-acetyl-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comput Assist Tomogr 1994;18:697-704
44. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med 1995;33:595-600
45. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259
46. Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
47. Cummings JL. Vascular subcortical dementias: clinical aspects. Dementia 1994;5:177-180
48. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neural 1993;50:873-880
49. Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986;36:340-345
50. Mori E, Ishii K, Hashimoto M, Imamura T, Hirono N, Kitagaki H. The role of functional brain imaging in evaluation of vascular dementia. Presented at the 3rd International Conference on Harmonization of Dementia Drug Guideline, 1998
51. Chabriat H, Pappata S, Levasseur M, Fiorelli M, Tran Dinh S, Baron JC. Cortical metabolism in posterolateral thalamic stroke: PET study. Acta Neurol Scand 1992;86:285-290
52. Bondareff W, Raval J, Woo B, Hauser DL, Colletti PM. Magnetic resonance imaging and the severity of dementia in older adults. Arch Gen Psychiatry 1990;47:47-51
53. Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-143
54. Giubilei F, Bastianello S, Paolillo A, et al. Quantitative magnetic resonance analysis in vascular dementia. J Neurol 1997;244: 246-251
55. Christiansen P, Schlosser A, Henriksen O. Reduced N-acelylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995;13: 457-462
56. Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997;37:372-377
57. 1H spectroscopic imaging of human brain at 4.1T using image segmentation. Magn Reson Med 1996;36:21-29
58. Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 1995;33:755-759
59. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998:40: 822-831